Dr. Nir Barzilai's perspective is that Big Pharma pours significant money into drug development but none into development for aging as a disease indication because the FDA has not yet approved aging as a disease indication, despite aging being the number one risk factor for most chronic diseases.

causalpending

Speaker

Ford Brewer

Evidence Quote

“dr. Barzilai is very excited about the idea of approving a medication for the indication of aging his point is the Big Pharma pour a lot of money into drug development but none of them are pouring money into drug development for aging because fda has yet approved aging as a disease indication”

Source

Longevity: TAME study funded! Metformin Trial for Anti-Aging— Dr. Ford Brewer MD MPH
Created: 8/11/2026, 1:17:18 AM

Your notes

Loading notes...